AwardTape · Defense awards · Research and development · Health R&D · W81XWH19C0193
W81XWH19C0193: -$1.1M definitive contract to Emergent Product Development Gaithersburg Inc
Emergent Product Development Gaithersburg Inc holds a definitive contract from Department of the Army with -$1.1M obligated since Oct 2023 and $5.7M obligated over its life, against a ceiling of $5.7M. Latest action Jul 17, 2024.
Creation of an fda approved analgesic ketamine drug with auto injector delivery system.
| PIID | W81XWH19C0193 |
|---|---|
| Type | definitive contract |
| Company | Emergent Product Development Gaithersburg Inc |
| Agency | Department of the Army |
| Contracting office | W4PZ USA MED RSCH ACQUIS ACT |
| Category | Research and development · Health R&D |
| PSC | AN93 R&D- MEDICAL: OTHER (ADVANCED DEVELOPMENT) |
| NAICS | 541715 RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) |
| Obligated since Oct 2023 | -$1.1M |
| Total obligated (lifetime) | $5.7M |
| Ceiling (base and all options) | $5.7M |
| Base date | Sep 26, 2019 |
| Latest action | Jul 17, 2024 |
| End date | Feb 29, 2024 |
| Actions since Oct 2023 | 1 |
| Pricing | Cost plus fixed fee |
| Competition | Full and open competition |
| Place of performance | MD |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial